Fundraising Fox
Find your path to Shelia
263 people in our graph share verified history with Shelia — schools, employers, funds. One of them is your warm intro.
Brendan KellyunlockedShelia: together at Q32 Bio (2020–2021)
×3Shelia: together at Q32 Bio
Shelia: together at ARIAD Pharmaceuticals, Inc.
×7Shelia: together at Atlas Venture
Founder & Chief Scientific Officer at Q32 Bio
Intro paths
→
In turn, Shelia can intro founders to Q32 Bio's investors below.
Q32 Bio's investors · 9
5AM VenturesSan Francisco · $100K – $4M checksACORN BIOVENTURESNew York · since 2020Agent CapitalWalthamAtlas VentureCambridge · $500K – $1M checks · since 2020CU Healthcare Innovation FundAuroraOrbiMedNew York · $1M – $75M checks · since 2020OUP (Osage University Partners)Bala Cynwyd · $1M – $20M checksSanofi VenturesCambridge · $5M checksVivo PandaPalo Alto
Co-founders at Q32 Bio
MH
Michael HolersCo-founder
Experience
- Atlas VentureAdvisorcurrent2021 — presentCambridge, Massachusetts, United States
- Q32 Bio Inc.Co-founder, Chief Scientific Officer and President of Researchcurrent2017 — presentCambridge, Massachusetts, United States
- Yale University School of MedicineAdjunct Associate Professor, Dept. of Internal Medicine, Section of Pulmonary2016 — 2021New Haven, CT
- Atlas VentureEntrepreneur In Residence2016 — 2020Cambridge, MA
- BiogenVice President, Tissue Injury and Fibrosis2015 — 2016Cambridge, MA
- BiogenSenior Director, Tissue Injury and Fibrosis2013 — 2015Cambridge, MA
- BiogenSenior Director, BG00011 program executive2012 — 2013Cambridge, MA
- StromedixVice President, Research2008 — 2012
- Biogen IdecDirector, Immunology2007 — 2008
- Biogen IdecResearch Head, Fibrosis / Associate Director, Molecular Cell Biology and Immunology2003 — 2007Cambridge, MA
- Biogen IdecSenior Scientist / Principal Scientist / alphavbeta6 Project Leader, Inflammation1999 — 2003Cambridge, MA
- ARIAD Pharmaceuticals, Inc.Principal Scientist / Staff Scientist, Biology and Signal Transduction1996 — 1999Cambridge, MA
- Repligen CorporationResearch Scientist / Principal Investigator, Inflammation and Molecular Pharmacology1992 — 1996
- Yale University, Department of BiologyPostdoctoral Research Fellow1988 — 1992New Haven, CT
Frequently asked questions
- Who is Shelia Violette?
- Founder & Chief Scientific Officer at Q32 Bio
- Where does Shelia Violette work?
- Shelia Violette is Founder & Chief Scientific Officer of Q32 Bio.
- What companies did Shelia Violette found?
- Shelia Violette founded Q32 Bio.
- Where did Shelia Violette go to school?
- Shelia Violette studied at Yale University (Ph.D., Pharmacology).
Founder mafias
Yale University mafia435
Also came through, then founded or led a company.
Atlas Venture mafia33
Also came through, then founded or led a company.
Josh ResnickVenture PartnerFounded Synolo Therapeutics +3Nessan BerminghamVenture PartnerFounded Korro Bio +2Romesh SubramanianEntrepreneur In ResidenceFounded RaNA Therapeutics +2Phillip SamayoaVenture PartnerFounded Generation Bio +2Sumit AgarwalAssociateFounded Ariodata +2Simon ReadEntrepreneur in ResidenceFounded Mariana Oncology +2
Same school
Also attended Yale University1,087
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)
+ 1,081 more
Shared employers
Also worked at Yale University School of Medicine82
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpAlley (Welsh) OlshanskyAdvisor at Casdin CapitalSophie RobinsonSenior Associate at Cure VenturesMichael RechtChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
+ 76 more
Also worked at Atlas Venture71
Karim FarisInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesKristen LaguerreExecutive Partner at MPM BioImpactJeanne HenryCFO at Excel Venture ManagementGretchen McCareyChief Financial Officer at Castle Island VenturesKate GunioController at Long Ridge Equity Partners
+ 65 more
Also worked at Biogen99
Jigar RaythathaInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityJohn McCabePortfolio Company CFO & COO at Longwood Fund
+ 93 more
